Skip to main content

Corient Private Wealth LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1948780 MIAMI, FL

Position in TEVA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,556,119
+$24,863 QoQ
Shares Held
51,664
+5.3% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
14 quarters on record
Voting authority Sole 71.97840882421967.ToString("F0")% Shared 0.ToString("F0")% None 28.021591175780337.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Corient Private Wealth LLC holds $108,358,523 across 27 Drug Manufacturers - Specialty & Generic names. TEVA ranks #7 (1.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 TEVA
Teva Pharmaceutical Industries Ltd
This page
51,664 $1,556,119

All Filings in TEVA

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,556,119 51,664
2025-12-31 $1,531,256 49,063
2025-09-30 $772,043 38,220
2025-06-30 $662,690 39,540
2025-03-31 $693,647 45,130
2024-12-31 $1,252,973 56,850
2024-09-30 $1,230,315 68,275
2024-06-30 $1,458,161 89,733
2024-03-31 $772,522 54,750
2023-12-31 $1,292,847 123,836
2023-09-30 $1,288,617 126,335
2023-06-30 $524,479 69,652
2023-03-31 $791,765 89,465
2022-12-31 $638,080 69,965